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ABSTRACT 
Childhood overweight and obesity affects more and more children. Whilst associations of 
childhood overweight with later outcomes such as hypertension, diabetes and cardiovascular 
disease have been well documented, less is known about the association of childhood 
overweight and obesity with kidney disease. We review the existing evidence for the 
association of childhood obesity with markers of childhood and adult kidney disease. Whilst 
there is some evidence for an association, studies have not been able to distinguish between 
childhood being a sensitive time to develop later kidney problems, or whether observed 
associations of childhood obesity with poor outcomes are driven by greater lifelong exposure 
to obesity.  
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Introduction 
 
Over the last two to three decades the prevalence of childhood overweight and obesity has 
increased in many parts of the world.[1,2] In developed countries, the prevalence of 
overweight or obesity has increased from 6.9% in boys and 16.2% in girls in 1980 to 23.8% 
in boys and 22.6% in girls in 2013. Over a similar time span, in developing countries the 
prevalence of overweight or obesity increased from 8.1% in boys and 8.4% in girls in 1980, 
to 12.9% in boys and 13.4% in girls.[3] The majority of overweight or obese children live in 
developing countries, where the rate of increase has been more than 30% higher than that in 
developed countries.[4]  
 
Adulthood obesity has been identified as a risk factor for a variety of chronic conditions 
including hypertension, diabetes, heart disease, high cholesterol, stroke, and certain 
cancers.[5,6] Tracking of obesity from childhood into adulthood is acknowledged.[7] 
Correspondingly, research has also focused on the impact of childhood obesity on morbidity 
and premature mortality in adulthood.[8,9] 
 
A growing number of studies have concluded that adulthood obesity increases the risk for 
kidney disease.[10] This may be a secondary effect after the development of diabetes and/or 
hypertension. A recent meta-analysis of 39 cohorts involving 630,677 participants who at 
baseline had no evidence of CKD and who had had a mean follow-up of 6.8 years [11], found 
that obesity increased the relative risk (RR, 95% Confidence Interval) of developing low 
eGFR (eGFR < 60 mL/min/1.73m2): 1.28, 1.07–1.54 and albuminuria (1+ at dipstick or an 
albumin creatinine ratio of ≥3.4 mg/mmol): 1.51, 1.36–1.67. There is weak evidence in adults 
that bariatric surgery may improve renal function[12] but there have been no randomised 
controlled trials and there is a lack of long term follow up studies[13]. 
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These findings may lead us to believe that childhood overweight or obesity will similarly 
increase the risk of adulthood kidney disease. However, few studies have directly examined 
this, and consequently our understanding is limited.  
 
The aim of this review is to see whether there is any evidence for an association between 
obesity during childhood and adult CKD. This included examining the evidence for an 
association of obesity with renal function markers in childhood (including a discussion of the 
study designs involved and measurements used), renal function post paediatric renal 
transplantation that compare obese to non-obese recipients, the evidence for the effect of 
bariatric surgery on renal function in the paediatric age, before moving on to studies that 
examined the association of childhood obesity with adult CKD. Relevant literature was 
identified in Pubmed, Medline, Embase and Scopus using the following terms as well as 
MESH terms for:  Obesity OR overweight OR weight gain OR body mass index OR 
metabolic syndrome AND Child OR children OR paediatric OR paediatrics OR adolescence 
OR  teenage OR teenagers OR young AND microalbuminuria OR albuminuria Or proteinuria 
OR hyperfiltration OR glomerular filtration rate OR kidney OR renal and included only 
studies that had a full text available in English, leaving out numerous conference abstracts. 
 
Studies in the paediatric age on the association of obesity with early markers of kidney 
disease 
 
Discussion of study designs used in the paediatric age group 
Studies carried out in paediatric populations on the possible association between childhood 
obesity and early changes in renal filtration and microalbuminuria are listed on Tables 1 and 
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2 respectively, and consisted of cross sectional studies, “case-control” studies and case series 
reports. The majority of studies have a cross sectional design where obesity and renal 
function are measured at the same point in time. A key step in establishing a causal role for 
obesity is that it should precede the measured effect on renal function. Therefore, cross 
sectional studies make it hard to attribute a causal effect of obesity on kidney function. Other 
studies are described as “case-control studies” and typically compared renal function in 
children who are obese (labelled by authors as “cases”) to renal function in children who are 
not obese (labelled by authors as “controls”). We have used inverted commas, as this design 
is not a standard case-control design as defined by epidemiologists who would recruit cases 
(those with renal disease) and controls (those without renal disease) and investigate 
prevalence of recorded pre-existing obesity before onset of renal disease. In all “case-control” 
studies on this topic however, the same problem arises as for the cross-sectional studies – 
renal function is measured at the same time as the obesity status and therefore there cannot be 
any inference made on the direction of causality. In addition, there are many reasons to doubt 
whether participants recruited from obesity clinics and their comparator groups are truly 
representative (i.e. findings generalizable to the general population), and whether the 
comparisons made are valid, i.e. adjusted for confounding factors related to attending obesity 
clinics and factors related to recruiting controls. They are joined by a number of case series 
reports, which provide no comparison group. Well-powered prospective population based 
cohort studies would provide an opportunity to measure obesity prior to the onset of renal 
function abnormalities. They are likely to be less biased than case control studies, provided 
that losses to follow up are kept to a minimum. Unfortunately, to our knowledge, no such 
cohort studies have been carried out to date.  
 
Problems of measuring obesity and kidney function in the paediatric age 
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The association has been measured most often either as the difference in mean estimated 
glomerular filtration rate (eGFR) which involve creatinine and less often on cystatin C 
concentrations or level of albuminuria or micro-albuminuria in obese children compared to 
children with normal weight for age and sex. Cystatin C based eGFR are believed to be less 
influenced than creatinine by changes in muscle mass[14]. In a meta-analysis of studies 
comparing creatinine to cystatin C based eGFR in adults and children, most of whom had 
some form of kidney disease, Roos et al[15] concluded that cystatin C was more accurate. 
The most commonly used measure for obesity is BMI with obesity and overweight classified 
according to WHO growth data[16]. Other measures such as waist circumference and waist to 
height ratio have also been used. Associations have been measured using either simple or 
adjusted correlation coefficients, with the measure of obesity and either eGFR or level of 
micro-albuminuria as continuous variables. These factors make the interpretation of the 
findings difficult. Differences in the findings may be explained further by differences in the 
range of BMI studied, age and sex of participants, age of onset of obesity and its duration, 
ethnicity, diet and other confounders as well as by differences in the choice of substrate and 
equations to estimate GFR and by differences in the conditions of measurements of urine 
albumin (e.g. diurnal effects, exercise, degree of hydration, timed versus spot samples, single 
or multiple urine sampling). In a large population based study involving 4,305 children aged 
6.0 years Miliku et al [17] showed that BMI was not associated with creatinine based eGFR 
and that BMI was negatively associated with cystatin C based eGFR. The effect was 
relatively small (–0.61ml/min/1.73m2, 95% CI –0.96 to –0.26 per unit increase in BMI 
standard deviation score (SDS), p <0.01). However, they showed that creatinine based eGFR 
but not cystatin C based GFR was influenced by fat mass (2.68ml/min/1.73m2, 95% CI 2.14 
to 3.21 per 1 SD increase in fat mass percentage, p<0.001) and by lean mass percentage (-
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2.74 ml/min/1.73m2, 95% CI –3.27 to –2.20 per unit increase in lean mass percentage, 
p<0.001). 
 
Which statistical association answers the question? 
In the search for “independent” effects of obesity, many studies present measures of effect 
adjusted for risk factors which may be on the causal pathway between obesity and renal 
function, for example blood pressure, insulin resistance, abdominal obesity, HbA1c. For 
epidemiologists the question is: Is Obesity a risk factor for CKD? This means that what is of 
most importance from a public health perspective is the overall effect of obesity, either acting 
through direct nephrotoxic effects or acting indirectly on the kidneys by its effects in rising 
blood pressure or causing diabetes with their ensuing effects on the kidneys. From this 
perspective the overall effect of obesity needs to take into account age, sex, smoking status, 
socio-economic status and possibly ethnicity, as the key confounders. Therefore, many of 
these studies are over-adjusted. 
 
Main findings of studies to date 
Table 1 summarises the findings of studies on eGFR in relation to obesity. The cross-
sectional population based studies found a mix of positive, negative and no associations for 
eGFR with BMI, whilst for children from obese clinic populations compared to controls there 
seems to be more of a consistent positive association between eGFR and BMI. The study by 
Pacifico et al[18] showed that obese children were more likely than children with normal 
BMI to have a low eGFR as well as being more likely than children with normal BMI to 
hyperfiltrate. These findings might possibly be explained by a changing effect of obesity on 
eGFR depending on the duration of obesity. This is an important factor which has not been 
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measured in this study nor in any of the other listed studies, as most of these only assess 
overweight or obesity at a single time-point. 
 
Most population-based studies on microalbuminuria have shown either no association with 
obesity or higher micro-albuminuria in children with normal BMI (Table 2). The reason for 
this is not clear and some authors have suggested that the finding of micro-albuminuria in 
non-obese children and adolescents might be confounded by orthostatic proteinuria. 
However, micro-albuminuria has been found in obese children in studies based on obesity 
clinics, possibly linked to higher blood pressure.  
 
Paediatric obesity and renal allograft function 
The situation in which a recipient receives a new kidney is a unique model in which the 
influence of recipient-specific factors such as obesity on the transplant kidney function can be 
prospectively explored. There are a number of retrospective studies on the effect of paediatric 
obesity on subsequent renal allograft function during childhood. Obesity is common in 
children receiving a renal transplant and the first 4 months post-transplantation have been 
found to be a particularly sensitive period for weight gain[19]. This is thought to be at least in 
part mediated by steroid immunosuppressive therapy [20].  
 
In a retrospective review of the records of 76 renal allograft recipients from 1994-2000 
Mitsnefes et al.[21] found pre-transplant obesity to be associated with decreased allograft 
function after renal transplantation. Paediatric patients who were obese (BMI ≥ 95th 
percentile) both prior to transplant and 1 year post-transplant had lower mean directly 
measured GFR than both those who were non-obese prior to transplant but became obese by 
1 year post-transplant (46.1 ± 15.0 mL/min/1.73 m2 v 57.7 ± 24.5 mL/min/1.73 m2, p < 0.05) 
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and those who were non-obese prior to transplant and 1 year post-transplant (46.1 ± 15.0 
mL/min/1.73 m2 v 60.4 ± 21.5 mL/min/1.73 m2, p < 0.01). The impact of paediatric obesity 
on long-term outcomes in paediatric patients with renal transplant was studied in an analysis 
of data from the North American Paediatric Renal Transplant Cooperative on 6658 paediatric 
age recipients. This showed that there had been an increase in the proportion of obese 
children from 8.2% in transplant recipients during the years 1987–1995 to 12.4% in children 
transplanted during the years 1996–2002[22]. This study found no overall difference in 
patient mortality nor graft survival between obese and non-obese children. However, in a 
post-hoc subgroup analysis it found a greater risk for death in obese children than non-obese 
children aged 6 to 12 years, and greater risk of living donor graft loss in obese than non-obese 
children aged 13-17 years. A study of 197 children from Brazil found decreased graft 
survival at 36 months post-transplant in children who had had an increase equal to or greater 
than 1 standard deviation in BMI between 1 month and 6 months post-transplant[20]. In a 
more recent study of 750 renal transplant recipients in Australia, aged 2 to 18 years and with 
a median follow-up of 8.4 years, obesity was associated with a 60% greater risk of graft loss 
(hazard ratio (HR) 1.61, 95% CI 1.05 – 2.47) compared to children with normal BMI. There 
was no association between BMI and acute allograft rejection[23].  
 
In summary, there are some data from the paediatric transplant population suggesting that 
obesity of the transplant recipient may be associated with accelerated graft loss.  
 
Effects of bariatric surgery on renal function in paediatric age patients 
Another way of looking at this question is to investigate the effect of weight reduction 
through bariatric surgery performed in children and adolescents on their subsequent kidney 
function. In a case report published in 2009, Fowler et al[24] described the resolution of 
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proteinuria resistant to medical treatment after bariatric surgery on a 15 year old girl. This 
was associated with a reduction in her BMI from 56.8 to 32 kg/m2 post-surgery.  The impact 
of bariatric surgery on renal function was described in a cohort of 242 severely obese 
adolescents[25] with a mean age of 17±1.6 years, 29% of whom were aged 13-15 years. Post 
bariatric surgery there was an average increase in cystatin C based eGFR of 3.9 (95% CI 2.4–
5.4) ml/min/1.73m2 per 10 kg/m2 decrease in BMI (p<0.0001). The majority of improvement 
in renal function occurred in those with a baseline eGFR of <90 ml/min/1.73 m2, whose mean 
(+/-SD) baseline eGFR was 76 +/- 12 ml/min/1.73 m2. In this group, eGFR improved by 34% 
to 102 +/-  28 ml/min/1.73 m2 at the 3-year follow-up evaluation (P < 0.0001). Amongst 
children with albuminuria pre-surgery, there was a fall in the geometric mean from a pre-
surgery level of  74 mg/g (95% CI 45–121 mg/g) to 17 mg/g (95% CI 10–28 mg/g) at 3 years 
(P < 0.0001) post bariatric surgery. In 69% of children albuminuria normalized by the 2-year 
follow-up evaluation, and in 75% albuminuria resolved by 3-years post bariatric surgery. This 
study did not have a comparator group, there were no standardised selection criteria for 
surgery, and in addition 24–29% of the 3 year follow up data were missing. It is important to 
recognise that bariatric surgery is often followed by a change in diet, and if proteinuria was 
related to high blood pressure in those sensitive to salt, then it may not have been the surgery 
itself driving those changes in proteinuria over time. The evidence from studies in adults has 
already been mentioned[13,12]. There have been no randomised controlled trials in adults 
and many of the studies are underpowered and potential confounding by factors such as those 
mentioned remains a possibility. 
 
What do epidemiological studies in the paediatric age show?  
In summary, there is clear evidence that childhood obesity is associated with cardiovascular 
risk factors in adulthood, and that obesity in adulthood is associated with markers of incident 
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CKD. The data are equivocal about whether an association between childhood obesity and 
renal function markers in childhood exists amongst children of the general population, whilst 
in clinic-populations of referred obese children there appears to be a subgroup of children 
with albuminuria and reduced eGFR. It may be that associations are difficult to detect 
depending on the timing of when the child was overweight and became obese, and how 
kidney function was measured (bearing in mind the limitations of creatinine based equations). 
In contrast, the evidence from the paediatric renal transplantation population is very 
suggestive in that those who are most obese have accelerated graft loss. In addition there are 
suggestive cross-sectional data on children aged between 5 and 19 years with eGFR of 30-90 
mL/min/1.73 m2 and a diagnosis of CKD participating in the prospective cohort “Chronic 
Kidney Disease in Children” (CKiD) [26] . Children were divided into non-glomerular 
(n=513) and glomerular (n = 224) forms of CKD. Using univariate linear regression, in the 
non-glomerular group BMI was not related to either urinary protein or eGFR but waist 
circumference (WC) was associated with an increase in urinary protein of 7.51% (95% CI 
0.45 – 15.06, p<0.05) and no association with eGFR; in the glomerular group, BMI and WC 
were related to eGFR (BMI: 6.81%, 95% CI 2.67 – 11.12%, p<0.0; WC: by 4.34%, 95% CI 
0.00 – 8.88%, p<0.05) but neither BMI nor WC were related to urinary protein. The main aim 
of the study was a comparison between BMI and WC as measures of obesity in this group of 
patients with established CKD and the conclusion was that WC added limited information to 
BMI in this cohort. However, these cross-sectional data suggest that the association of 
obesity with renal markers amongst children with CKD may depend on the type of 
underlying renal damage.  
 
Epidemiological studies of the association of childhood obesity with adulthood kidney 
function  
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There have been a number of studies of risk factors with onset in childhood for CKD in adult 
life, either using ESRD or laboratory measurements to confirm CKD.  
 
Muntner et al[27] reported on 15 cases of ESRD in the Bogalusa cohort. Seven of the cases of 
ESRD had an unknown aetiology and among other features they had a higher BMI recorded 
in childhood compared to their counterparts. This study was of limited scope given the 
weakness in the ascertainment of cases of ESRD and absence of detailed follow up data from 
childhood to the time when ESRD occurred.  
 
Vivante et al. used a sample of 1.2 million Israelis examined prior to their military 
conscription at age 17 years in the period 1967-1997, linked to the Israeli ESRD registry for 
the period 1980-2010[28]. In an adjusted model, overweight (BMI between 85th and 95th 
centile) and obesity (BMI ≥ 95th centile) at age 17 years were both strongly associated with 
all-cause treated ESRD (HR 3.00, 95% CI: 2.50-3.60 and 6.89, 95% CI: 5.52-8.59, 
respectively). The authors could not adjust for confounders such as socioeconomic status or 
smoking.  
 
A third, carefully designed matched case control study[29] examined the incidence of ESRD 
up to the age of 40 years in relation to risk factors measured in adolescence in males only 
using data collected at conscription to the Swedish Military service between 1970 and 1975 
when most were aged 18 or 19 years of age. The National Patient Register was used to 
ascertain data on new cases of ESRD from 1985, at least 10 years after the conscription 
examinations, to reduce confounding by undiagnosed kidney disease in adolescence. There 
were 534 incident ESRD diagnoses and 5,127 men were selected as controls, representing the 
most powerful study to date. Elevated BMI at conscription was associated with increased 
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ESRD risk with an adjusted OR of 3.53 (95% CI 2.04-6.11, p<0.001) for BMI > 30 kg/m2 
compared to those with normal BMI (18.5-25kg/m2). The odds for ESRD were also increased 
but to a lesser extent in those who had been overweight (BMI at conscription between 25 and 
30 kg/m2) with an adjusted OR of 2.36 (1.79-3.13, p<0.001) raising the possibility of a dose 
effect by BMI. The possible confounding effects of social status, and smoking, and the role of 
the subsequent BMI trajectory post conscription or current BMI were not examined. 
 
In a nationwide population-based case control study using incident cases of CKD as defined 
by laboratory test results [30], overweight (BMI > 25 kg/m2) at age 20 was associated with 
increased odds for CKD in middle-aged men and women, relative to BMI < 25 kg/m2: OR 
(adjusted for age, education, smoking, alcohol, and use of paracetamol and salicylates) = 3.1 
(95% CI 2.1 to 4.8) in males and 3.0 (95% CI 1.4 to 6.1) in females. The problem of this and 
other health record database studies using routine creatinine tests to examine this question is 
that people with BMI have more cardiovascular risk factors and therefore get tested earlier 
for presence/absence of kidney disease, which introduces information bias in favour of 
finding an association between BMI and incident CKD. As not everybody was tested the 
same way, no definitive conclusions can be drawn from this or similar routine health care 
studies.  
 
To our knowledge the Medical Research Council National Survey of Health and 
Development (NSHD), a socially stratified sample of 5362 singleton children born in one 
week in March 1946 in England, Scotland and Wales was the first study to systematically 
examine the effect of overweight throughout childhood and adulthood on later kidney 
function in a general population cohort [31,32]. Repeated measurements of BMI between 
ages 2 and 20 years were used to derive childhood overweight latent classes (‘never’, ‘pre-
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pubertal only’, ‘pubertal onset’ or ‘always’), which were then related to measures of CKD at 
age 60-64 years: creatinine- or cystatin C-based eGFR < 60 ml/min/1.73 m2 or urine albumin-
creatinine ratio (uACR) ≥ 3.5 mg/mmol. Relative to being in the never overweight latent 
class, being in the pubertal onset or always childhood overweight latent classes was 
associated with CKD at age 60-64 years when considering cystatin C-based eGFR (odds ratio 
(OR) 2.04, 95% CI 1.09, 3.82). The associations with CKD at age 60-64 years defined by 
creatinine-based eGFR (OR 1.27, 95% CI 0.71, 2.29) and uACR (OR 1.33, 95% CI 0.70, 
2.54) were less marked but in the same direction. Adjustment for social class, lifestyle and 
health factors (e.g. smoking) had little impact on the effect estimates. The low prevalence of 
CKD (resulting in low statistical power) and the lack of repeated measurements of creatinine 
and cystatin C meaning that the CKD chronicity criterion was not met were limitations of the 
study[33]. 
 
Overall, there is some suggestive evidence from the NSHD cohort study, but otherwise 
studies may be affected by the co-occurrence of social deprivation and smoking. 
  
Mechanisms 
The mechanisms relating childhood obesity to later CKD are not well researched[34], which 
is perhaps unsurprising considering that a follow-up over several decades may be needed to 
detect associations. 
 
From studies conducted in animals and adults, there is evidence that obesity can lead to 
inflammation, oxidative stress, abnormal lipid metabolism, activation of the renin-
angiotensin-aldosterone system, and increased production of insulin and insulin resistance. 
These abnormalities could lead to haemodynamic abnormalities, lipotoxicity and 
inflammation in the kidneys constituting the main mechanisms for obesity related renal 
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damage[35]. It is thought that the most important mechanism might be haemodynamic 
abnormalities affecting the renal microvasculature leading to hyperfiltration, development of 
proteinuria and ultimately to glomerulosclerosis and a reduction in GFR [36-38]  Studies in 
young people include a study in young men (mean age 18.4 years), where hyperfiltration was 
associated with overweight, elevated blood pressure, and low high-density lipoprotein 
cholesterol with multivariate-adjusted OR of glomerular hyperfiltration of 6.6 (95% CI 3.8-
11.6), 1.8 (95% CI 1.0-3.0), and 2.5 (95% CI 1.5-4.3), respectively[39]. Franchini et al[40] 
found that the prevalence of microalbuminuria and hyperfiltration was similar between obese 
and youths with Type 1 diabetes and higher than their control peers (6.0 vs. 8.0 vs. 0%, 
p=0.02; 15.9 vs. 15.9 vs. 4.3%, p=0.03, respectively). Possible mechanisms mediating 
paediatric kidney injury and are thought to include inappropriate activation of the renal 
angiotensin aldosterone system, the inflammatory role of adipokines secreted by fat tissue 
such as leptin and adiponectin, renal effects of dyslipidaemia and insulin resistance.[41-43]   
Children who are overweight are at a higher risk of developing high blood pressure and 
diabetes, though there is a lack of evidence for effects independent of adulthood 
overweight.[8] A further study using NHSD data investigated the mediatory roles of diabetes, 
hypertension and obesity in the relationship between low birth weight and later renal 
function[44], and found that the observed association between low birth weight and low 
eGFR was not confounded by socioeconomic position and was not explained by diabetes or 
hypertension. There was some evidence that it was stronger in study members who were 
overweight in adulthood. These findings thus again suggested that overweight/obesity may 
accelerate kidney function loss in the presence of other kidney problems.  
 
 
Challenges and future research directions 
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Although there is a plethora of studies looking at childhood obesity and renal function, they 
do not provide enough evidence for a direct causal pathway between childhood obesity and 
adult CKD. The evidence that obesity is associated negatively with renal function in the 
paediatric age is not conclusive, and it may be instead that obesity may accelerate renal 
function loss in the context of other (subclinical) renal damage. 
 
One deficiency in research to date, has been an inability to distinguish whether the effects of 
childhood obesity on CKD are due to childhood obesity in and of itself (i.e. that childhood is 
a ‘critical period’ or a ‘sensitive period’[45]), or whether the observed effect is merely due to 
childhood obesity been indicative of greater lifelong exposure to obesity pressure (i.e. an 
‘accumulation of risk’[45]). In addition, to date authors have not fully explored the role of 
other factors that co-occur with obesity such as a bad diet with high calories and salt leading 
to both obesity and high blood pressure. The challenge of research investigating the question 
whether childhood obesity causes kidney damage independently of adulthood obesity 
(‘sensitive period’) is the statistical necessity to have sufficient subjects who become normal 
weight in adulthood after being obese in childhood to make analysis tenable, and the fact that 
reasons for weight loss and the way weight loss occurs may itself impact on kidney health. 
There were very few subjects in the NSHD data who lost weight which meant that data were 
not available to address this important question.[32] 
 
The number of years lived with adulthood obesity are known to be directly associated with 
the risk of all-cause and cause-specific mortality[46]. Since the obesity-related metabolic, 
oxidative and inflammatory damage to many tissues and organs may accumulate over 
time,[47] kidney dysfunction resulting from lifelong obesity beginning in childhood would 
not be unexpected. To date we have not seen evidence that CKD prevalence or ESRD 
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incidence increase as a result of increasing prevalence of childhood obesity. However, based 
on the data from the NHSD, the lag time between childhood overweight and adult CKD may 
well be several decades.[32,31]  
 
It is unclear whether childhood obesity causes pre-adulthood kidney damage.  A further 
investigation of this question would require repeated follow up of very sensitive kidney 
function markers in a prospective birth cohort study. In general population cohorts this 
necessitates large sample sizes. Such a study should carefully characterise nutrition and 
physical activity to better understand which of the pathways that lead to obesity may have 
most impact on kidney health. 
 
The finding that obesity strengthens the association of low birth weight with later poorer 
kidney function is particularly worrying in the setting of low middle income countries which 
are undergoing a rapid rate of urbanization with an associated rise in obesity.[48]  Indeed, in 
the Indian Migrant study, the years lived in urban settings were associated with decreased 
eGFR amongst rural-urban migrants in age-adjusted analyses[49].  
 
Conclusions 
The association between adulthood obesity and kidney disease is well-documented, but the 
evidence for a similar effect of childhood obesity is patchy. Although there remains much 
research to be done in this area, in view of the overall impact of childhood obesity on health 
it is becoming apparent that efforts to prevent and treat obesity early in life could potentially 
have an impact on the progression, costs and comorbidities of kidney disease[43]. It is 
thought that reducing the amount of time that individuals live with obesity (“obesity-years”) 
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by preventing early onset may be critical in minimising a variety of long-term hazards of 
obesity on health[47].  
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Table 1: Summary of studies on Childhood Obesity and early changes to GFR detected in childhood 
Author, year of 
publication 
n Age  
in years 
Sampling 
 
Exposure Outcome* Findings Direction of 
association 
between 
obesity and 
eGFR 
Cross-sectional 
studies 
       
Lee, 2017[50] 
 
Population based 
2584 12 – 17y 
 
 
National Health 
and Nutrition 
Examination 
Survey 
(NHANES) 
population 
survey, USA 
Metabolic risk 
factors 
including 
BMI z score, 
derived from 
own data 
Hyperfiltration defined as 
eGFR ≥120 mL/min/1.73 
m2. 
Creatinine based    eGFR 
(ml/min/1.73m2), Schwartz 
equation: 
0.413 × height (cm)/ serum 
creatinine (mg/dL)   
 
Outcome measure: 
Adjusted Odds Ratio for 
hyperfiltration 
 
 
BMI z score OR for 
hyperfiltration adjusted for 
sex, age, race and income: 
0.96 (0.82–1.12), p = 0.578 
 
 
= 
Tajbakhsh, 2017 
[51]  
 
Population based 
367 10 – 18  
 
Random 
sampling 
from national 
survey of 5625 
BMI 
 
 
 
Creatinine based e GFR 
(ml/min/1.73m2), Schwartz 
equation: 
0.413 × height (cm)/ serum 
BMI:  
r = 0.121, p = 0.02 
 
 
+ 
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rural and urban 
school based 
children: 
Childhood and 
Adolescence 
Surveillance and 
Prevention of 
Adult 
Noncommunica
ble Disease 
III (CASPIAN 
III), Iran 
 
Waist 
circumference 
 
Waist-height 
ratio 
creatinine (mg/dL) 
 
Outcome measure: 
Correlation coefficient 
 
 
Waist circumference: 
r = 0.190, p< .001 
 
Waist-height ratio: 
r = 0.070, p = 0.18 
 
 
+ 
 
 
= 
Marmarinos, 
2016[52] 
 
Population based  
536 4 – 17  
 
Teaching 
hospital 
paediatric clinic, 
excluding 
children with 
chronic 
conditions or on 
anti-
inflammatory 
agents, diuretics, 
anticonvulsants 
and antibiotics, 
Greece. 
BMI 
  
Cystatin-C (mg/L) 
 
Outcome measure: 
Multivariate regression 
coefficient 
Regression coefficient for 
BMI (β) adjusted for sex, 
age (in a variable category 
that indicates the existence 
of puberty) and blood 
pressure: 
β: +0.03 (0.01, 0.04) 
p=0.001 
- 
Correia-Costa, 
2015[53] 
 
Population based  
313 8 – 9y Birth cohort 
Generation XXI, 
Portugal 
BMI z-score 
based on 
WHO growth 
data[16] 
 
Creatinine-based and 
cysteine-C based eGFR: 
using Schwartz, Filler, 
Zappitelli-Comb, 
Schwartz-Comb formulae 
(ml/min/1.73m2) and 24 
hour creatinine clearance.  
Regression coefficient (β) 
for BMI z score, adjusted 
for age and sex: 
 
eGFR Schwartz-R: 
-0.51 (-2.17 –1.16),  
p=0.548 
 
 
 
 
= 
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Outcome measure:  
Multivariate linear 
regression coefficient 
 
Filler eGFR: 
−4.26 
(−5.77 to −2.74), 
p < 0.001 
 
Zapitelli-Comb: 
−2.77 
(−4.16 to −1.38), 
p < 0.001 
 
Schwartz-Comb: 
−1.10 
(−2.01 to −0.18), 
p = 0.014. 
 
24h Cr Cl: 
−3.54 
(−6.52 to −0.57), 
p = 0.020 
 
- 
 
 
 
 
- 
 
 
 
 
- 
 
 
 
 
- 
Di Bonito, 
2014[54] 
 
Population based  
901 
 
6 – 16y General 
paediatric clinic 
with diagnosis 
of allergy, 
gastro-
oesophageal 
reflux, 
overweight, 
obesity, 
excluding 
chronic liver, 
renal cardiac, 
BMI Creatinine based eGFR 
(ml/min/1.73m2),  
Schwartz formula:  
0.413 x height (cm)/serum 
creatinine (mg=dl). 
 
eGFR: mild-low eGFR (< 
20th percentile), high 
eGFR (>80th 
percentile), and 
intermediate eGFR (20-
BMI in: 
low-mid eGFR =  
26+/-6  
 
Intermediate eGFR = 
25+/-6  
 
high eGFR 
26+/-6, 
 
p=0.10 
= 
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endocrine and 
infection 
conditions, Italy 
80th percentile and 
considered as 
the reference category) 
 
Outcome measure: 
Comparison of mean BMI 
Ma, 2014 [55] 
 
Population based  
5222 6 – 17 
 
Stratified 
sampling by 
ethnic group, 
China 
BMI Creatinine (μM) 
 
Outcome measure: 
Multivariate linear 
regression coefficient 
Regression coefficient for 
BMI (β) adjusted for uric 
acid, glucose, triglycerides, 
cholesterol, high and low-
density cholesterol (but not 
height): 
β (6 – 7y) = -0.113(SE 
0.265), p=0.479 
 
β (8 – 9y) = -0.37(SE 
0.284), p=0.313 
 
β (10 – 11y) = 0.041(SE 
0.097), p=0.042;  
 
β (12 – 13y) = 0.081(SE 
0.074), p<0.001  
 
β (14 – 15y) = 0.18 (SE 
0.093), p<0.001,  
 
β (16 – 17y) = 0.171(SE 
0.22), p<0.01. 
 
 
 
 
 
 
= 
 
 
= 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
Soylemezoglu, 
2012[56] 
 
3079 5 – 18 National 
population 
survey, cluster 
BMI 
categories 
based on CDC 
Creatinine based 
eGFR(ml/min/1.73m2),  
Schwartz formula: 
eGFR in: 
 
Underweight: 
- 
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Population based 
sampling, 
Turkey 
growth 
data[57].  
 
k × length (cm)/creatinine 
(mg/dL) where k = 0.70 in 
males ≥13 years and 0.55 
for the rest 
 
Outcome measure: 
Comparison of mean eGFR 
133.30 ± 24.45 
 
Normal: 
129.19 ± 22.95 
 
Overweight: 
128.18 ± 22.79 
 
Obese: 
122.71 ± 21.64 
 
(p < 0.001). 
 
Koulouridis, 2010 
[58]  
 
Population based  
166 
 
3 – 18  Healthy 
children 
recruited from 
sport academies 
and through 
local media, 
Corfu 
BMI  
 
Waist 
circumference 
Creatinine based eGFR 
(ml/min/1.73m2), 
Schwartz formula: 
k x height(cm)/creatinine 
(mg/dl) x 88.4 where k = 
61.9 in males ≥ 13y and 
48.6 for the rest 
 
Outcome measure: 
Correlation coefficient 
eGFR correlation 
coefficient: 
 
with BMI: 
r=0.28, p=0.0004 
 
with Waist circumference: 
r=0.419,  
 
p<0.00001 
 
 
 
+ 
 
 
+ 
 
 
 
Cindik, 2005[59] 
 
Population based  
85 7 – 16 Obesity 
screening survey 
in two primary 
schools in two 
cities in two  
regions Turkey  
BMI  
BMI 
categories 
Obese ≥ 95th, 
controls < 
85th, using 
data from 
First National 
Health and 
Creatinine based eGFR 
(mls/min), Leger formula: 
56.7 x weight (kg) + 0.142 
x height2 (cm2)]/serum 
creatinine (μmol/l)  
 
Outcome measure: 
Comparison of mean eGFR 
eGFR in: 
 
Obese: 
141.8+/-48.2 
 
Controls: 
118.6+/-28.4, 
 
p=0.092. 
= 
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Nutrition 
Examination 
Study, 1971 to 
1974[60] 
  
 
Correlation between BMI 
and eGFR: 
r=0.39 p=0.001 
 
 
+ 
“Case1” control 
Pacifico 2016[18] 
 
“Case” control 
study  
 
 
924 
 
3 - 17 Hospital 
outpatient 
Clinics and from 
randomly 
selected local 
schools, Italy 
BMI 
categories 
based on 
WHO growth 
data[16] 
Creatinine based eGFR 
(ml/min/1.73m2), Schwartz 
equation: 
0.413 × height (cm)/ serum 
creatinine (mg/dL) 
 
Outcome measure: 
Comparison of mean BMI 
eGFR in: 
 
Obese:  
115 (104–134)  
Normal: 
108 (100–118), p<0.0001. 
 
Numbers with: 
eGFR < 90: mL/min/1.73 m2, 
Obese: 
22 (6.7%) 
Normal: 
1 (0.77%), p<0.01  
 
eGFR > 139: mL/min/1.73 m2, 
Obese: 
56 (17.0%)  
Normal: 
6 (4.6%), p<0.0001 
 
 
+ 
 
 
 
 
 
 
- 
 
 
 
 
 
+ 
Bartz, 2015[61] 
 
“Case” control 
study2  
 
58 14 - 16 Medical centre 
and through 
media 
advertising, 
USA 
BMI category 
and response 
to oral 
glucose 
tolerance test 
(OGT) 
 
Creatinine based e GFR 
(ml/min/1.73m2): Schwartz 
equation: 
0.413 × height (cm)/ serum 
creatinine (mg/dL) 
 
 
eGFR in: 
 
Normal BMI: 
94.0+/- 4.6  
 
Overweight and Normal 
OGT: 
+ 
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 Outcome measure: 
Comparison of mean eGFR 
106.0+/-3.9 
 
Overweight and pre-DM: 
108.3+/-4.0.  
 
Normal vs Overweight-
PreD, p=0.049 
 
Linear regression model: 
percentage body fat β = 
0.40, p = 0.03  
 
 
 
 
 
 
 
 
+ 
Franchini 2015[40] 
 
 
 
“Case” control 
study  
 
318 
 
6 – 18y Obesity 
Clinic, Diabetic 
clinic and from 
admissions to 
paediatric ward 
for minor 
trauma, 
fractures, Italy 
 
BMI z score 
(based on 
Italian 
reference 
values) 
 
 
Creatinine and cysteine-C 
based eGFR: 
Bouvet formula: 
63.2(1.2/cysteine)0.56 
(1.09/creatinine)0.35 
(weight/45)0.3 (age/14)0.4 
 
Outcome measures: 
Comparison of adjusted 
mean eGFR 
 
Multivariate linear 
regression coefficient 
 
 
eGFR adjusted for age, 
sex, and pubertal stage: 
 
Obese =  
116.15±1.67 
 
Controls: 
105.06±1.82 
p <0.001 
 
Type 1 DM with normal 
weight and Obese group 
had similar degree of 
hyperfiltration 
 
Linear regression 
coefficient (β) between 
BMI z-score and eGFR 
adjusted for age, sex and 
pubertal stage:  
r=0.328, p<0.001 
+ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
+ 
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Falakaflaki, 
2012[62] 
 
“Case” control 
study  
 
 
 
92 
 
7-12y School children, 
matched on age 
and sex, 
Iran 
 
BMI 
categories 
based on 2000 
CDC growth 
data[57] 
Creatinine based e GFR 
(ml/min/1.73m2), Schwartz 
equation: 
k × height (cm)/ serum 
creatinine (mg/dL) 
 
Outcome measure: 
Comparison of mean eGFR 
Overweight: 
98.90 +/- 4.59 
 
Normal: 
96.37+/-3.73, p=0.49 
= 
Savino, 2011[63] 
 
 
“Case” control 
study  
 
 
157 5 - 17 Obesity clinic, 
and from 
admissions to 
paediatric ward 
with minor 
illnesses, once 
recovered, Italy. 
BMI 
categories: 
Obese= >97th 
percentile for 
age and sex. 
Normal: 
within 2 SD 
of the 50th 
centile 
Creatinine based eGFR 
(ml/min/1.73m2), Schwartz 
formula: 
k × length (cm)/creatinine 
(mg/dL) where k = 0.70 in 
males ≥13 years and 0.55 
for the rest 
  
Outcome measure: 
Comparison of mean eGFR 
Obese: 
144.3 ± 26.7  
 
Normal: 
136.8 ± 12.7,  
p = >0.05. 
 
= 
“Case3” series: 
Xiao, 2014[64] 
  
“Case” series 
242 ≤19  Consecutive 
cases pre- 
bariatric surgery 
at each of five 
Teen-LABS 
centres, USA 
BMI Cystatin C-based eGFR 
(ml/min/1.73m2): 
Larsson formula 
eGFR = 77.24 × (Cystatin-
C)−1.2623 
 
Outcome measure: 
Multivariate linear 
regression coefficient 
Regression coefficient (β) 
for BMI adjusted for sex, 
age, race, DM, 
hypertension, HOMA-IR, 
HbA1c, ferritin, serum 
albumin, transferrin, 
dyslipidaemia, kidney 
stones: 
 
β (per 10-unit increase in 
BMI):  −7.90 
- 
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Abbreviations:  
BMI = Body Mass Index, CDC = Centers for Disease Control and Prevention, DM = diabetes mellitus, eGFR = estimated Glomerular Filtration 
Rate, HOMA-IR = Homeostatic Model Assessment of Insulin Resistance, SD = standard deviation 
 
Notes: 
* = Some studies may have been designed to assess another primary outcome, however in this table we have listed the renal outcome of interest 
for this systematic review 
 
1 = cases defined by exposure = obesity 
2 = cases defined by exposure, group 1 = overweight and normal oral glucose test (OGT), group 2 = overweight and pre-diabetes (impaired 
fasting glucose or impaired glucose tolerance)  
3 = cases defined by exposure = obesity 
 
 
 
 
 
 
 
(−11.60,−4.20), p = < 0.01 
.  
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Table 2: Summary of studies on Childhood Obesity and proteinuria detected in childhood 
Author, year of 
publication, type 
of study 
n Age 
in years 
Sampling 
 
Exposure Outcome* Findings  Direction of 
association 
Cross sectional studies: 
Larkins[65], 
2017 
 
population 
based 
 
975 5 - 18 Australian Health 
Survey stratified, 
multistage area design 
population survey  
Overweight or 
Obesity, based on 
WHO growth 
data[16] 
 
Microalbuminuria 
defined as UACR ≥30 
mg/g or ≥3.4 mg/mmol 
 
Outcome measure:  
Adjusted Odds Ratio 
for microalbuminuria 
Overweight/Obese OR, 
adjusted for age and sex:  
0.34 (0.15–0.75), p = 
0.009 
- 
Cho[66], 2017 
population 
based 
 
1,976 10 - 19 Korean National 
Health and 
Nutrition Examination 
Survey (KNHANES) 
Obesity, based on  
Korean 
National Growth 
Data 
Obesity = BMI ≥ 
95th percentile or ≥ 
25 kg/m2  
Microalbuminuria 
defined as   
UACR ≥ 30 mg/g and < 
300 mg/g.  
  
Outcome measures: 
Comparison of 
prevalence 
Comparison of 
geometric means 
Prevalence in: 
Obese: 1.7% 
Normal: 3.2% p=0.238 
 
UACR (geometric mean 
+/- SE): 
 
Obese: 2.1 ± 0.2 
 
Non-obese: 3.2 ± 0.1  
p=0.001 
 
= 
 
 
 
- 
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Correlation coefficient 
Univariate coefficient (r) 
(UACR log transformed 
v BMI-SDS): 
r = -0.19, p < 0.001)  
 
- 
Machluf[67], 
2016 
 
population 
based 
    
113,694 17 Conscripts National 
Military Service, 
Israel 
Obesity, based on 
national growth 
data on BMI: 
Obesity: > 95th 
percentile  
Normal 5th to <85th 
Proteinuria: 
> 200 mg/24 h  
 
Outcome measure:  
Adjusted Odds Ratio 
for proteinuria 
Obesity OR, adjusted for 
country of birth, country 
of origin, year of birth, 
religion, 
education, intelligence 
score, residential 
environment, family size, 
and blood pressure: 
1.07 (0.59-1.94), p>0.05 
= 
Gracchi[68] 
2016 
 
population 
based 
 
1288 2 -<3 Prospective birth 
cohort study, 
Netherlands 
BMI Log UACR  
 
Outcome measure:  
Univariate linear 
regression coefficient 
β = 0.04 (−0.00–0.01),  
p = 0.063 
= 
Gurecka 
2016[69],  
  
population 
based 
 
2666 14 – 20 
 
State schools, 
Slovakia  
 
BMI 
 
Waist/Height ratio  
 
Microalbuminuria 
defined as UACR 2.5–
25.0 mg/mmol in boys, 
3.5–35.0 mg/mmol in 
girls  
 
Outcome measures:  
 
Comparison of mean 
BMI 
 
Comparison of  
Boys: 
BMI in: 
Normo-albuminuria 
group: 23.2 ± 3.8  
Micro-albuminuria 
group: 21.8 ± 3.0, 
p<0.05 
 
 
Waist/Height ratio in: 
Normo-albuminuria 
group: 0.45 ± 0.05 
 
- 
 
 
 
 
 
 
 
- 
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mean Waist/Height 
ratio 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Multivariate regression 
Micro-albuminuria 
group: 0.42 ± 0.04, 
p<0.01 
 
Girls: 
BMI in: 
Normo-albuminuria 
group: 22.0±3.4 
 
Micro-albuminuria 
group: 21.0±3.5, 
p>0.05 
 
 
Waist/Height ratio in: 
Normo-albuminuria 
group: 0.43±0.05 
 
Micro-albuminuria 
group: 0.43±0.05 
p>0.05 
 
Neither BMI, nor 
Weight/Height ratio nor 
other cardiovascular 
factors found to be 
associated with 
microalbuminuria in 
multivariate model in 
either gender 
 
 
 
 
= 
 
 
 
 
 
 
 
 
= 
 
 
 
 
 
 
 
= 
Rutkowski, 
2013[70] 
889 14 – 15 Independent schools, 
Poland 
BMI 
 
Albuminuria defined as 
UACR ≥30 mg  
Correlation coefficient r  
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population 
based 
 
Waist to Height 
ratio (WHtR) 
 
Outcome measure:  
Correlation coefficient 
BMI= −0.198, p>0.05 
 
WHtR= −0.151, p<0.01 
 
 
= 
 
- 
Okpere, 
2012[71] 
 
population 
based 
 
864 
 
10 - 19 Secondary schools 
selected by multistage 
sampling, Nigeria   
BMI categories 
based on  
CDC growth 
data[57] 
Microalbuminuria 
defined by urine 
dipstick strip reading of 
20mg/L or more 
 
Outcome measure:  
Adjusted Odds Ratio 
for microalbuminuria 
Obesity OR adjusted for 
DM, hypertension, FH of 
DM, FH of hypertension: 
 
0.859 (0.474 - 1.555) 
p>0.05 
= 
Hirschler, 
2010[72] 
 
population 
based 
 
1564 5 - 14 Random selection of 
schools, Argentina 
BMI categories 
based on CDC 
growth data[57] 
 
BMI 
 
 
UACR 
 
Natural log UACR 
(Log n UACR) 
 
Outcome measure: 
Multivariate linear 
regression coefficient 
Adjusted Odds Ratio 
for microalbuminuria 
Log n UACR model, 
BMI β = –0.03; p < 
0.001) adjusted by 
gender, waist 
circumference, age and 
systolic and diastolic 
blood pressure. 
 
Adjusted OR for UACR 
≥ 3rd quartile by gender, 
waist circumference, age 
and systolic 
and diastolic blood 
pressure OR in 
Overweight/Obese: 0.77 
(0.64–0.92) 
 
 
- 
 
 
 
 
 
 
 
- 
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Haysom 
2009[73] 
 
population 
based 
 
2266 4 - 14 Government-run 
primary schools with 
high Aboriginal 
population, Australia 
BMI SD quartiles 
based on 
international 
normative data SD 
(z) score 
 
Albuminuria defined as 
UACR (mg/mmol) ≥ 
3.4mg/mmol (on urine 
dipstick)  
 
 
Outcome measure:  
Adjusted Odds Ratio 
for albuminuria 
OR for albuminuria by 
BMI quartile adjusted for 
ethnicity, age, gender, 
birthweight, blood 
pressure and categories 
of isolation, disadvantage 
and region. 
BMI SD -4.8 to -0.8:  
OR = 1 
BMI SD -0.7 to 0.1:  
OR = 0.67 (0.44 – 1.04) 
BMI SD 0.2 – 0.7:  
OR = 0.65 (0.42 – 1.02) 
BMI SD 0.8 – 6.9:  
OR = 0.51 (0.32 – 0.82) 
(p<0.001)),  
p for trend <0.05  
- 
Haysom1 
2009[74] 
 
population 
based 
 
1,432 4 – 14 
 
2-year 
follow 
up 
Government-run 
primary schools with 
high Aboriginal 
population, Australia 
BMI SD (z 
score)   
 
 
Albuminuria defined  
as albumin-creatinine 
ratio of 3.4 mg/mmol or 
greater. 
 
 
 
 
 
Outcome measure:  
Adjusted Odds Ratio 
for microalbuminuria 
Prevalence of 
Albuminuria: 
 
Baseline: 7.3% 
(Obesity Baseline: 7.1%) 
 
At 2 years: 1.5% 
(Obesity at 2 years 5.3%) 
 
OR for microalbuminuria 
adjusted for ethnicity, 
age, sex, birth weight, 
systolic blood pressure, 
diastolic blood pressure, 
isolation category, 
 
 
 
 
 
 
 
 
 
= 
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disadvantage category 
and school, at 2-year 
follow up: 
 
BMI SD -4.8 to -0.8:  
OR 1 
BMI SD -0.7 to 0.1:  
OR 0.83 (0.24 – 2.96) 
BMI SD 0.2 – 0.7:  
OR 1.31 (0.31 – 5.57) 
BMI SD 0.8 – 6.9:  
0.15 (0.01 – 2.05,  
p>0.05 
Haysom1 
2009[75] 
 
population 
based 
 
1506 4 - 14  
 
4-year 
follow 
up 
Government-run 
primary schools with 
high Aboriginal 
population, Australia 
Body mass index 
(BMI) SD (z 
Score)   
 
Albuminuria defined  
as albumin-creatinine 
ratio of 3.4 mg/mmol or 
greater. 
 
 
 
 
 
Outcome measure:  
Adjusted Odds Ratio 
for microalbuminuria 
Prevalence of 
Albuminuria: 
 
Baseline: 7.3% 
(Obesity Baseline: 7.1%) 
 
At 4 years: 2.4% 
(Obesity at 4 years 5.0%) 
 
BMI z score OR for 
microalbuminuria 
adjusted for ethnicity, 
age, sex, birth weight, 
systolic blood pressure, 
diastolic blood pressure, 
isolation category, 
disadvantage category 
and school, at 4-year 
follow up: 
 
 
 
 
 
 
 
 
 
= 
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BMI SD -4.8 to -0.8:  
OR 1 
BMI SD -0.7 to 0.1:  
OR 1.07 (0.45–2.54) 
BMI SD 0.2 – 0.7:  
OR 0.73 (0.28–1.87) 
BMI SD 0.8 – 6.9:  
OR 0.66 (0.25–1.75), 
p>0.05 
Nguyen 
2008[76] 
 
population 
based 
 
2515 12 - 19 National Health and 
Nutrition 
Examination Survey 
Overweight = 
(BMI of ≥95th 
percentile) 
 
Waist 
circumference 
Microalbuminuria 
defined as UACR  
≥30 mg/g and < 300 
mg/g 
 
Outcome measure: 
Comparison of 
prevalence of 
microalbuminuria 
Prevalence of 
microalbuminuria:  
 
non-Overweight = 8.7% 
Overweight = 0.3%, 
p = 0 .005 
 
Prevalence of 
microalbuminuria:  
 
No abdominal obesity: 
7.9%  
 
Abdominal Obesity: 
1.0%,  
p = 0.03 
 
 
- 
 
 
 
 
 
 
- 
Jafar 2005[77] 
population 
based 
3621 5 - 14 National Health 
Survey of Pakistan 
(NHSP) over 4 years 
(1990–1994) by the 
BMI Proteinuria defined as ≥ 
30 mg/dl (on urine 
dipstick)  
 
BMI OR for proteinuria 
adjusted by height, socio-
economic status, 
= 
 41 
 
 Pakistan Medical 
Research Council, 
  
Outcome measure:  
Adjusted Odds Ratio 
for proteinuria 
ethnicity, urban dwelling, 
systolic blood pressure: 
 
0.96 (0.90–1.02), p>0.05 
Cindik, 2005 
 
population 
based 
 
85 7 – 16 Obesity screening 
survey in two primary 
schools in two cities 
in two  
regions Turkey  
BMI categories 
Obese ≥ 95th, 
controls < 85th, 
using data from 
First National 
Health and 
Nutrition 
Examination Study, 
1971 to 1974[60] 
  
Urine microalbumin 
excretion (mg/24h) 
 
Outcome measure: 
Comparison of means 
of microalbuminuria 
Urine microalbumin 
excretion in: 
 
Obese: 
7.3+/-10.9 mg/24h 
 
Controls: 
5.9+/-5.7 mg/24h, 
 
p=0.105 
= 
 
“Case2” control studies: 
 
Pacifico, 
2016[18]  
 
“Case” control 
924 
 
3 - 17 Hospital outpatient 
Clinics and from 
randomly selected 
local schools, Italy 
Obesity, using 
WHO growth 
data[16] 
 
Microalbuminuria 
defined as ≥30 mg/24h 
and < 300 mg/24h 
 
Outcome measure: 
Comparison of 
prevalence of 
microalbuminuria 
Prevalence of 
Microalbuminuria: 
 
Obese: 13 (4.0%) 
 
Normal: 0 (0%),  
 
p<0.0001  
+ 
Franchini, 
2015[40] 
 
“Case” control 
318 
 
6 – 18y Obesity Clinic, 
Diabetic clinic and 
from admissions to 
paediatric ward for 
minor trauma, 
fractures, Italy 
 
BMI z-score  
 
 
Log Albumin Excretion 
Rate (log AER) 
 
Microalbuminuria 
defined as AER = 20 – 
200 μg/min 
 
Log AER adjusted for 
age, sex, and pubertal 
stage: 
 
Obese = 0.978±0.022  
 
Controls = 0.852±0.024, 
+ 
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Outcome measures: 
Comparison of adjusted  
mean log AER 
Multivariate linear 
regression coefficient 
 
p<0.001 
 
 
Regression coefficient 
for BMI z-score adjusted 
for age, sex and pubertal 
stage: 
β = 0.135, p=0.017 
 
 
 
 
 
+ 
Bartz, 2015[61] 
“Case” control 
study3 
 
58 14 - 16 Medical centre and 
through media 
advertising, USA 
BMI category and 
response to oral 
glucose tolerance 
test (OGT) 
 
 
 
 
 
 
 
 
 
 
 
 
Percentage body fat 
 
Urine microalbumin 
excretion (UACR) 
(mg/g) 
 
 
Outcome measures: 
Comparison of mean 
UACR 
Correlation coefficient 
Urine Microalbumin 
excretion in: 
 
Normal BMI group: 
4.15+/- 0.53  
 
Overweight and normal 
OGT: 
6.03+/- 0.75  
 
Overweight and 
pre_DM: 
5.74+/- 0.98, 
 
p>0.05 
 
Non-significant 
correlation between 
lnUACR and percentage 
body fat in multivariate 
model 
= 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
= 
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Falakaflaki, 
2012[62] 
 
“Case” control 
study 
92 
 
7-12y School children, 
matched on age and 
sex, 
Iran 
 
BMI categories 
based on CDC 
growth data[57] 
Albumin/creatinine 
ratio (ACR) 
 
Outcome measure: 
Comparison of mean 
ACR 
Albumin/creatinine ratio 
in: 
 
Overweight: 
0.049+/-0.04 
 
Normal: 
0.043+/-0.03, 
p=0.74 
 
= 
Savino, 
2011[63] 
 
“Case” control 
study 
157 5 - 17 Hospital Obesity 
clinic, and from 
admissions to 
paediatric ward with 
minor illnesses, once 
recovered, Italy. 
BMI SD 
categories: Obese= 
>2SD for age and 
sex. 
Normal: within 2 
SD of the 50th 
centile 
Urine albumin 
excretion rate (AER) 
(μg/min) 
 
Outcome measure: 
Comparison of mean 
AER 
Correlation coefficient 
Urine AER in: 
 
Obese: 
10.2 ± 9.5 
   
Non-Obese: 
7.5 ± 1.9, 
 
p=0.010 
 
Correlation coefficient 
BMI and AER: r=0.301, 
p=0.0001  
+ 
 
 
 
 
 
 
 
 
 
+ 
Csernus, 
2005[78] 
“Case” control 
study 
165 8 - 17 Obesity clinic, 
Hungary 
BMI  
 
Obesity defined as 
a ratio between 
actual body weight 
and the ideal body 
weight for age, 
gender and height 
> 1.2 
UACR (mg/g) 
Outcome measures: 
Comparison of median 
UACR 
Correlation coefficient 
 
Median UACR in: 
 
Obese = 11.7 mg/g, 
interquartile range 12.9 
mg/g  
 
Normal = 9.0 mg/g, 
interquartile range 5.1 
mg/g,  
+ 
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(corresponding to 
overweight or 
obesity by WHO 
definition[16]) 
 
 
 
 
p = 0.003 
 
 
Correlation between  
BMI v UACR: 
r =0.22, p <0.05  
 
 
 
 
+ 
“Case4” series  
Xiao, 2014[64] 
 
“Case” series 
242 ≤19 Consecutive cases 
pre- bariatric surgery 
at each of five Teen-
LABS centres, USA 
BMI Microalbuminuria 
defined as UACR ≥30 
mg/g < 300 mg/g  
 
Outcome measure: 
Multivariate linear 
regression coefficient 
 
No association between 
BMI and UACR in 
model adjusted for sex, 
age, race, DM, 
hypertension, HOMA-IR, 
HbA1c, ferritin, serum 
albumin, transferrin, 
dislipaedaemia, kidney 
stones 
= 
Radhakishun, 
2013[79] 
 
“Case” series 
408 3 - 19 Paediatric Obesity 
clinic 
BMI z score 
 
 
 
Micro-albuminuria 
defined as UACR 2.5–
25.0 mg/mmol in boys, 
3.5–25.0 mg/mmol in 
girls 
 
Outcome measure: 
Comparison of mean 
BMIz score 
 
Adjusted Odds ratio for 
microalbuminuria 
 
BMI z score: 
 
Microalbuminuria group 
3.6±0.7  
 
Normo-albuminuria 
group: 
3.2±0.6,  
p = 0.047 
 
BMI z score OR for 
microalbuminuria  
adjusted by sex, pubertal 
stage and ethnicity not 
given, p=0.054 
+ 
 
 
 
 
 
 
 
 
 
= 
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Lurbe, 2013[80] 
 
 
“Case” series 
134 9 - 18 Paediatric Obesity 
clinic 
BMI z score based 
on WHO growth 
data[16] 
 
Overweight: 
1 to <2.0 SDS 
 
Moderately Obese: 
2.0 – 2.5 SDS 
 
Severely Obese: 
>2.5 SDS 
of 2.0 or more, 
namely, moderate 
obesity as a z score 
Microalbuminuria 
defined as  
UACR ≥30 mg/g or in 
the “high-normal 
range” (UACR: 15–29 
mg/g) 
 
Outcome measure:  
Correlation coefficient 
Correlation coefficient 
BMI z score and log 
UACR: 
r=0.24, p<0.05 
+ 
Sanad, 2011[81] 
 
“Case” series 
150 2 - 11 Paediatric Obesity 
clinic, Egypt 
BMI Microalbuminuria 
defined as  
UACR ≥30 mg/g and 
<300 mg/g 
 
Outcome measure:  
Adjusted Odds Ratio 
for microalbuminuria 
BMI OR for 
microalbuminuria 
adjusted for age, gender, 
abdominal obesity, 
hypertension, 
triglycerides, LDL, HDL 
insulin resistance and 
metabolic syndrome: 
1.15 (1.02–4.55) p<0.01 
+ 
Burgert, 
2006[82] 
“Case” series 
277 12 - 15 Obesity clinic 
 USA 
BMI z score 
 
 
Microalbuminuria 
defined as UACR 
between 2mg/mmol and 
20 mg/mmol 
 
BMI z score in: 
 
Normal UACR group: 
 2.46 (2.41, 2.49) 
Microalbuminuria group: 
 2.39 (2.27, 2.51), 
p = 0.42 
= 
 46 
 
Abbreviations:  
BMI = Body Mass Index, CDC = Centers for Disease Control and Prevention, DM = diabetes mellitus, HDL = high density lipoprotein, HOMA-
IR = homeostatic model assessment of insulin resistance, LDL = low density lipoprotein, OR = odds ratio, SD = standard deviation, UACR = 
urine albumin-to-creatine ratio 
 
Notes: 
* = Some studies may have been designed to assess another primary outcome, however in this table we have listed the renal outcome of interest 
for this systematic review 
 
1 = this study was a prospective cohort but the data on BMI and albuminuria was analysed cross-sectionally 
 
2 = cases defined by exposure = obesity 
 
3 = cases defined by exposure, group 1 = overweight and normal oral glucose test (OGT), group 2 = overweight and pre-diabetes (impaired 
fasting glucose or impaired glucose tolerance)  
 
4 = cases defined by exposure = obesity 
 
Outcome measure: 
Comparison on mean 
BMI z score 
 
 
